Abstract
We tracked the effective reproduction number (Rt) of the predominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant Omicron BF.7 in Beijing in November–December 2022 by fitting a transmission dynamic model parameterized with real-time mobility data to (i) the daily number of new symptomatic cases on 1–11 November (when China’s zero-COVID interventions were still strictly enforced) and (ii) the proportion of individuals who participated in online polls on 10–22 December and self-reported to have been test-positive since 1 November. After China’s announcement of 20 measures to transition from zero-COVID, we estimated that Rt increased to 3.44 (95% credible interval (CrI): 2.82–4.14) on 18 November and the infection incidence peaked on 11 December. We estimated that the cumulative infection attack rate (IAR; that is, proportion of the population infected since 1 November) in Beijing was 75.7% (95% CrI: 60.7–84.4) on 22 December 2022 and 92.3% (95% CrI: 91.4–93.1) on 31 January 2023. Surveillance programs should be rapidly set up to monitor the evolving epidemiology and evolution of SARS-CoV-2 across China.
Similar content being viewed by others
Main
After implementing the ‘zero-COVID’ policy for more than two years, China has recently begun to adjust its coronavirus disease 2019 (COVID-19) response strategies, notably by announcing the 20 measures on 1 November and further the 10 measures on 7 December 2022 (refs. 1,2). Although increasing vaccination coverage among the elderly and protection of high-risk groups were emphasized, the 20 measures included restricting testing coverage, cutting quarantine period for close contacts or inbound travelers and suspending the tracing of secondary contacts1. The 10 measures further prohibited region-wide mass testing, and home isolation or quarantine was allowed2. Since then, Omicron infections have spread rapidly in major cities in China, including Beijing, where the predominant SARS-CoV-2 variant, Omicron BF.7, has put great pressure on the healthcare system since early December3,4.
Regular mass testing and intensive contact tracing were suspended in late November, and nucleic acid testing has been conducted on a voluntary basis thereafter5. As such, the daily number of confirmed cases reported by Beijing Municipal Health Commission (http://wjw.beijing.gov.cn/) was no longer an accurate reflection of the epidemic, making it difficult to assess the transmission dynamics. Here, we tracked the effective reproduction number of Omicron BF.7 in Beijing in November–December 2022 (refs. 6,7) using our previous epidemic nowcast framework, which combined real-time mobility data and case data in the disease transmission models8.
Effective reproduction number (R t) of Omicron in Beijing
We categorized the COVID-19 response adjustments in Beijing into three stages:
-
i.
Stage 1 (1–11 November): Zero-COVID strategy was strictly implemented with regular mass testing, intensive contact tracing and lockdown of residential buildings or communities once polymerase chain reaction (PCR)-positive infections and their close contacts were traced.
-
ii.
Stage 2 (12–25 November): Although mass testing and contact tracing were maintained after the announcement of 20 measures on 11 November, lockdown was limited to the residential buildings or only the floors or units where people with PCR-positive infections lived.
-
iii.
Stage 3 (after 25 November): The requirements of regular mass testing, intensive contact tracing and lockdown were gradually relaxed and finally suspended on 30 November. Nucleic acid testing is conducted on a voluntary basis after the announcement of 10 measures on 7 December.
We parameterized the disease transmission model with the daily number of passengers from Beijing Mass Transit Railway (MTR) and Beijing Subway, which collectively manage 22 of 27 rapid transit lines in Beijing (Fig. 1). We fitted the model to two data streams to estimate the effective reproduction number Rt: (i) the daily number of symptomatic cases reported to Beijing Municipal Health Commission between 1 and 11 November (Stage 1), when the testing and reporting behavior were relatively stable and (ii) the proportion of participants who self-reported to have ever tested positive by PCR or rapid antigen test (RAT) since 1 November, based on Weibo and WeChat online polls conducted via convenience sampling between 10 and 22 December (Fig. 1 and Extended Data Table 1). See Methods for details.
Within one week of the announcement of 20 measures, Rt increased from 1.04 (95% CrI: 0.84–1.29) on 11 November to 3.44 (95% CrI: 2.82–4.14) on 18 November (Fig. 2). In response to the increasing number of cases, public health and social measures (PHSMs) were implemented: residents were urged to stay home over the weekend of 19–20 November; 95% of staff were advised to work from home during the week of 21–25 November and kindergartens and primary and secondary schools were closed on 21 November. Consequently, mobility decreased, and Rt dropped to 0.99 (95% CrI: 0.83–1.16) on 27 November.
The surge of infections saturated the capacity of PCR testing and quarantine facility in late November. The requirement of regular mass testing, intensive contact tracing and lockdown were gradually relaxed and finally suspended with the announcement of 10 measures. PHSMs were relaxed and consequently Rt increased to 2.43 (95% CrI: 2.11–2.52) on 7 December (Fig. 2), which was substantially higher than Rt of 1.9 under similar PHSMs in the early stage of Hong Kong’s Omicron wave in February–March 20229.
Omicron infections spread rapidly again starting from early December, and many symptomatic individuals and their close contacts self-isolated10. Within one week after the announcement of 10 measures, Beijing’s mobility dropped to low levels, and we estimated that Rt dropped below 1 on 11 December and to 0.72 (95% CrI: 0.30–0.93) on 14 December. The mobility level started to increase in the week of 17–23 December, and Rt increased to 1.09 (95% CrI: 0.39–1.96) on 19 December. We estimated that Rt dropped below 1 again on 21 December due to depletion of the susceptible population (Fig. 2).
Daily incidence and cumulative infection attack rate
We estimated the daily incidence and cumulative infection attack rate from the fitted model accordingly (Fig. 2). On 30 November, when regular mass testing was suspended, we estimated the daily number of infections was 94,272 (95% CrI: 52,270–160,042) in Beijing. The daily incidence increased rapidly since then and peaked on 11 December, with an estimated daily number of infections of 1.03 million (95% CrI: 0.61–1.49; that is, 4.7% of the population).
We estimated that the cumulative IAR was 43.1% (95% CrI: 25.6–60.9) on 14 December. The daily incidence slightly decreased between 11 and 16 December but started to increase again on 17 December coincident with increased mobility. We estimated that the cumulative IAR reached 75.7% (95% CrI: 60.7–84.4) on 22 December. Assuming that the mobility and population mixing level would remain at the same levels after 22 December, we estimated the cumulative IAR would reach 92.3% (95% CrI: 91.4–93.1) on 31 January 2023 (Extended Data Fig. 1).
In the base-case scenario above, we assumed each participant of the online polls underwent multiple RATs and the ascertainment probability of previous infection was 1 after 11 November (Fig. 2). As such, the actual IAR was likely to be slightly higher than our base-case estimates. As a sensitivity analysis, we included the ascertainment probability in the inference framework (Extended Data Fig. 2). The resulting estimate of ascertainment probability was 81.5% (95% CrI: 78.9–84.2). The corresponding estimated Rt was slightly higher (for example, 3.92 (95% CrI: 3.19–4.73) versus 3.44 (95% CrI: 2.82–4.14) on 18 November and 3.05 (95% CrI: 2.63–3.24) versus 2.43 (95% CrI: 2.11–2.52) on 7 December). The estimated cumulative IAR was higher accordingly, reaching 55.1% (95% CrI: 34.3–73.5) on 14 December and 88.5% (95% CrI: 80.1–93.0) on 22 December. Assuming that the mobility and population mixing level would remain at the same levels after 22 December, we estimated the cumulative IAR would reach 96.2% (95% CrI: 96.1–96.3) on 31 January 2023.
Discussion
Our study tracked Rt of the Omicron BF.7 variant in Beijing by fitting an epidemic transmission model parameterized with mobility data to early-stage case count and recent survey data on cumulative incidence8. When mass testing and confirmation of all cases become impossible during the surge of infections, it is important to continuously monitor infection prevalence in the community through various surveillance programs, such as REACT-type studies in the United Kingdom and Hong Kong11,12, wastewater surveillance13 and serological surveillance14. Given the rollout of the second booster vaccines, data from such surveillance studies could also inform the assessment of vaccine effectiveness in real time12,14.
By 22 December, we estimated that the Omicron epidemic had peaked in Beijing and 76% of the Beijing residents had been infected (Fig. 2). Assuming no changes in PHSMs or population behavior, we anticipated that the number of infections would start dropping toward the end of December and the pressure on the healthcare system would be alleviated in January 2023 (Extended Data Fig. 1). However, vaccination should be ramped up in the coming months in anticipation of new waves that might arise due to importation of different Omicron variants from increased population movement between Beijing and other provinces during the Spring Festival in January 2023.
Our study has several limitations. First, passenger statistics of Beijing MTR and Beijing Subway were the only real-time mobility data we found. These passengers only account for about 95% of Beijing’s subway volume and might not be representative of the population using other transportation means. Second, the subway mobility data might not be the best proxy for changes in contacts and hence Rt. During the week of 8–14 December, most of the population stayed home or self-quarantined and only made contact with their household members15. Thus, it is difficult to accurately estimate the rapid changes in population mixing and PHSM effectiveness. Third, our estimation relied on IARs inferred from the results of Weibo and WeChat online polls. As most active Weibo or WeChat users are between 18 and 60 years old, the poll results might not be representative of all age groups. Self-reported infection status or test results can also introduce bias, and the ascertainment probability of infection was uncertain. Future refinements of our framework should include more reliable data to estimate IARs, such as age-specific seroprevalence data14
Given that COVID-19 response strategies have been adjusted nationwide, the number of new infections is expected to surge across China. The epidemics in other major cities and counties might be similar to that of Beijing with multiple incidence peaks, especially when population mixing starts to increase after the first peak which is further exacerbated by the upcoming mass population movement during the annual Spring Festival. Surveillance programs should be rapidly set up to monitor the spread and evolution of SARS-CoV-2 infections; further work should be done to track the transmissibility, incidence and IAR of the epidemics.
Methods
Data
Ethics statement
The study was based on anonymized data that are publicly available. No ethical approval was required for use of the data.
Mobility data from Beijing Subway and Beijing MTR
Beijing Mass Transit Railway Operation Corporation Limited (https://www.bjsubway.com/, Beijing Subway) and Beijing MTR Corporation Limited (https://www.mtr.bj.cn/, Beijing MTR) operate 22 major lines out of 27 rapid transit lines in Beijing, which serve about 95% of the subway passengers daily. Both Beijing Subway and Beijing MTR publish the recorded daily number of trips regularly (https://weibo.com/bjsubway and https://weibo.com/bjmtr) and we obtained the data between 1 November and 22 December 2022, from their Weibo accounts (Extended Data Table 2).
Data from online polls conducted via Sina Weibo or Tencent WeChat
Since the announcement of 10 measures on 7 December 2022, verified Weibo and WeChat users have conducted online polls to track the proportion of participants who self-reported to be ever positive by PCR or RAT since 1 November, in view of the rapid increase of Omicron infections around them.
Sina Weibo has a verification policy to confirm the identity of a personal user or organization, similar to Twitter’s account verification (https://kefu.weibo.com/faqdetail?id=37). On Weibo, verified users can create Weibo online polls (https://kefu.weibo.com/faqdetail?id=20533). Similar to Twitter polls, the default duration of Weibo polls is 1 day and the poll results are instantly displayed. Also, the poll creators are able to stratify the poll results by provinces inferred from the IP addresses where the participants voted.
Similarly, verified Tencent WeChat users can register as a public account, which enables them to interact with subscribers and provide them with services. WeChat online polls can be conducted in public accounts with results stratified by provinces inferred from IP addresses (https://kf.qq.com/faq/161221FN7fi6161221NRBJzq.html).
In this study, we included data from 22 cross-sectional online polls conducted on Weibo or WeChat by verified users whose polls were read more than 100,000 times nationwide within the day posted (Extended Data Table 1). Results of these polls were publicly available, and there were two to four options in most of the polls; for example:
-
i.
Two-option polls (such as https://weibo.com/chinaetfs, 11 December)
-
a.
Option 1: I have tested positive in this wave (recovered or not yet recovered)
-
b.
Option 2: I have not tested positive in this wave
-
a.
-
ii.
Three-option polls (such as https://weibo.com/u/2987102112, December 10–14)
-
a.
Option 1: I have tested positive and recovered in this wave
-
b.
Option 2: I have tested positive but not yet recovered in this wave
-
c.
Option 3: I have not tested positive in this wave
-
a.
-
iii.
Four-option polls (such as https://weibo.com/u/7126731879, 10 December)
-
a.
Option 1: I have not tested positive
-
b.
Option 2: I have tested positive and recovered
-
c.
Option 3: I have tested positive but not yet recovered
-
d.
Option 4: I have tested positive twice
-
a.
Transmission model
We used our previous age-structured Susceptible-Exposed-Infectious-Removed (SEIR) model to simulate the transmission of Omicron in Beijing16:
where m was the number of age groups in the population; k=4 was the number of infectious states of the model; Sa(t), Ea(t) and Ra(t) were the number of susceptible, exposed and removed individuals in age group a at time t; Ia,i(t) was the number of individuals in the i-th infectious state of age group a at time t; Na was the total number of people in age group a; 1/γE was the duration from exposure to become infectious; and k/γI was the duration of being infectious. The mean generation time was calculated as \(T_{GT} = 1/\gamma _E + \frac{{k + 1}}{{2\gamma _I}}\), following the formulation of Svensson17.
Following our previous framework to parameterize SARS-CoV-2 transmission models with mobility data8, we formulated the average rate at which an individual in age group a made infectious contacts with age group b at time t (that is, βab(t) as
where cab was the contact rates between age group a and age group b from Mistry et al18 and g(t) was the normalized number of passengers of subway lines managed by Beijing Subway and Beijing MTR on day t (such that g(t)=1 on 1 November 2022).γ(t) was the scaling factor for the mobility data proxy g(t). Given the changes in PHSMs during the weeks of 12–25 November, we assumed γ(t) was γ1 between 1 and 11 November, increased linearly between 12 and 25 November from γ1 to γ2, and remained at γ2 after 25 November. γ1 and γ2 were estimated in the parameter inference (Extended Data Tables 3, 4).
The time-varying next generation matrix for this SEIR model was:
where Tg was the mean generation time.
The effective reproduction number Rt corresponded to the dominant eigenvalue of NGM(t)19,20. The incidence rate of infection and reported onsets at time t were calculated as follows:
where preport was the proportion of infections ascertained and reported as symptomatic cases by Beijing Municipal Health Commission (http://wjw.beijing.gov.cn/). Similarly, the cumulative IAR at time t was calculated as follows:
We assumed that the epidemic was seeded by M local infections on 1 November 2022.
Inference
The set of parameters that were subject to statistical inference, which we denoted by θ, included: (i) the seed size M, (ii) the scaling factors γ1 and γ2 and (iii) the ascertainment proportion preport between 1 and 11 November (Extended Data Table 3). We estimated θ from (i) the daily number of symptomatic cases reported to Beijing Municipal Health Commission between 1 November and 11 (Fig. 1) and (ii) the proportion of participants who reported to be positive by PCR or RAT since 1 November in Weibo or WeChat online polls conducted between 10 and 22 December (Extended Data Table 1).
The likelihood function L(θ) is a product of the two components L1(θ) and L2(θ). L1(θ) was formulated as below:
where ncase(t) was the daily number of symptomatic cases confirmed and reported by Beijing Municipal Health Commission between 1 and 11 November and Aonset(t) was daily number of infections from the model convoluted by the incubation period distribution, assuming no onset-to-confirmation delay under mass testing and intensive contact tracing between 1 and 11 November. Similarly, assuming each participant of the online polls underwent multiple RATs and the ascertainment probability of infection was 100% after 1 November, L2(θ) was formulated as:
where tpol,i was the time or date when Weibo or WeChat online poll i was carried out, npol,i was the number of participants of Weibo or WeChat online poll i and npos,i was the number of participants of Weibo or WeChat online poll i who reported to have ever tested positive by PCR or RAT since 1 November.
However, the sensitivity of RAT ranges between 70% and 80% for Omicron and thus the ascertainment probability of infection could be less than 100% after 1 November21. In a sensitivity analysis, we assumed that the ascertainment probability of infection (pascertain) was not 100%, and estimated pascertain and other parameters with the updated L2(θ) as:
L(θ) was formulated as follows:
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
We collated all data from publicly available data sources. All data included in the analyses are available in the main text or supplementary materials.
Code availability
All MATLAB codes are available at https://github.com/kathyleung/2022_12_24_Beijing_Rt_Omicron.
References
Xinhua. China Focus: China releases measures to optimize COVID-19 response; https://english.news.cn/20221111/d4399114a082438eaac32d08a02bf58d/c.html (2022).
Xinhua. China Focus: COVID-19 response further optimized with 10 new measures; https://english.news.cn/20221207/ca014c043bf24728b8dcbc0198565fdf/c.html (2022).
Xinhua. Beijing sets up fever clinics in all community health service centers; https://english.news.cn/20221213/2e070d9abcbd4362b990b7e8811b5642/c.html (2022).
Xinhua. Chinese vice premier stresses need to ensure smooth transition of COVID-19 response phases; https://english.news.cn/20221214/3c1d5934a43d47d4a016194acea7bd1d/c.html (2022).
Xinhua. Chinese mainland reports 2,249 new local confirmed COVID-19 cases; http://en.people.cn/n3/2022/1214/c90000-10183940.html (2022).
Global Times staff reporters. Omicron BF.7, major strain causing latest outbreak in Beijing, has strong infectious ability: medical expert. Global Times (https://www.globaltimes.cn/page/202211/1280588.shtml) (28 November 2022).
Xinhua. Explainer: Health experts shed light on key COVID-19 concerns through FAQs; https://english.news.cn/20221222/bfb706fb61ab43c9bf76420851ac131a/c.html (2022).
Leung, K., Wu, J. T. & Leung, G. M. Real-time tracking and prediction of COVID-19 infection using digital proxies of population mobility and mixing. Nat. Commun. 12, 1–8 (2021).
D24H@HKSTP and HKU WHO Collaborating Centre on Infectious Disease Epidemiology and Modelling. Modelling the fifth wave of COVID-19 in Hong Kong https://www.med.hku.hk/en/news/press/20220210-modelling-the-omicron-fifth-wave (10 February 2022).
Global Times staff reporters. China pivots from curbing infection to medical treatment, guarantees safe re-opening. Global Times (http://english.news.cn/20221227/95057dffb96a459b876dadd4ae818be2/c.html) (14 December 2022).
Elliott, P. et al. Rapid increase in Omicron infections in England during December 2021: REACT-1 study. Science 375, 1406–1411 (2022).
Tsang, N. N. Y., So, H. C., Cowling, B. J., Leung, G. M. & Ip, D. K. M. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(22)00732-0 (2022).
Deng, Y. et al. Use of sewage surveillance for COVID-19: a large-scale evidence-based program in Hong Kong. Environ. Health Perspect. 130, 057008 (2022).
Lau, J.J. et al. Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nat Med. (2023).
Baidu Map. China Urban Transportation Report https://jiaotong.baidu.com/congestion/city/urbanrealtime/ (2022).
Wu, J. T. et al. Inferring influenza infection attack rate from seroprevalence data. PLoS Pathog. 10, e1004054 (2014).
Svensson, Å. A note on generation times in epidemic models. Math. Biosci. 208, 300–311 (2007).
Mistry, D. et al. Inferring high-resolution human mixing patterns for disease modeling.Nat. Commun. 12, 323 (2021).
Diekmann, O., Heesterbeek, J. & Roberts, M. G. The construction of next-generation matrices for compartmental epidemic models. J. R. Soc. Interface 7, 873–885 (2010).
Diekmann, O. & Heesterbeek, J. A. P. Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation (John Wiley & Sons, 2000).
Bayart, J.-L. et al. Analytical sensitivity of six SARS-CoV-2 rapid antigen tests for omicron versus Delta variant. Viruses 14, 654 (2022).
Acknowledgements
We sincerely thank all participants of the Weibo or WeChat online polls and verified users who conducted the polls during the time when Omicron infections increased rapidly around them. The study would not be possible without their valuable input. This research was supported by Health and Medical Research Fund (grant 21200122 (K.L., J.T.W.), CID-HKU2 (J.T.W.) and COVID19F05 (K.L., G.M.L. and J.T.W.)), Health and Medical Research Fund Research Fellowship Scheme (grant 06200097 (K.L.)), General Research Fund (grant 17110020 (K.L.)) and the AIR@InnoHK (K.L., E.H.Y.L., C.K.H.W., G.M.L. and J.T.W.) administered by Innovation and Technology Commission of The Government of the Hong Kong Special Administrative Region. K.L. was supported by the Enhanced New Staff Start-up Research Grant from LKS Faculty of Medicine, The University of Hong Kong. The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Author information
Authors and Affiliations
Contributions
All authors designed the study, developed the model, analyzed data, interpreted the results and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Medicine thanks James Trauer and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling editor: Alison Farrell, in collaboration with the Nature Medicine team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Estimated Rt, daily incidence and cumulative infection attack rate in Beijing.
a, Estimated Rt between 1 November, 2022, and January 31, 2023, assuming that the mobility and population mixing level would remain at the same levels of December 22 between December 23, 2022 and January 31, 2023. Lines indicate the maximum a posteriori probability (MAP) estimates and shades indicate the 95% credible interval (95% CrI). b, Estimated daily number of infections between 1 November, 2022 and January 31, 2023. Lines indicate the maximum a posteriori probability (MAP) estimates and shades indicate the 95% credible interval (95% CrI). c, Estimated cumulative infection attack rates between 1 November, 2022 and January 31, 2023. Lines indicate the maximum a posteriori probability (MAP) estimates and shades indicate the 95% credible interval (95% CrI).
Extended Data Fig. 2 Estimated Rt daily incidence and cumulative infection attack rate in Beijing when the ascertainment probability after 1 November was estimated in the inference.
a, Estimated Rt between 1 November and 22 December. Lines indicate the maximum a posteriori probability (MAP) estimates and shades indicate the 95% credible interval (95% CrI). b, Estimated daily number of infections between 1 November and 22 December. Lines indicate the maximum a posteriori probability (MAP) estimates and shades indicate the 95% credible interval (95% CrI). c, Estimated cumulative infection attack rates between 1 November and 22 December. Lines indicate the maximum a posteriori probability (MAP) estimates and shades indicate the 95% credible interval (95% CrI).
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Leung, K., Lau, E.H.Y., Wong, C.K.H. et al. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November–December 2022. Nat Med 29, 579–582 (2023). https://doi.org/10.1038/s41591-023-02212-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02212-y
This article is cited by
-
Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status
The Egyptian Journal of Internal Medicine (2024)
-
Retrospective study about clinical severity and epidemiological analysis of the COVID-19 Omicron subvariant lineage-infected patients in Hohhot, China
BMC Infectious Diseases (2024)
-
Characterization and trajectories of hematological parameters prior to severe COVID-19 based on a large-scale prospective health checkup cohort in western China: a longitudinal study of 13-year follow-up
BMC Medicine (2024)
-
Perceived risk of COVID-19 hurts mental health: the mediating role of fear of COVID-19 and the moderating role of resilience
BMC Psychiatry (2024)
-
Effectiveness of inactivated COVID-19 vaccines in preventing COVID-19-related hospitalization during the Omicron BF.7-predominant epidemic wave in Beijing, China: a cohort study
BMC Infectious Diseases (2024)